The U.S. Court of Appeals for the Third Circuit ruled in favor of the U.S. Food and Drug Administration (FDA) in the case of Liquid Labs LLC v. FDA, upholding the agency’s marketing denial order (MDO) for Liquid Lab’s flavored e-cigarette products.
A final rule released today will fix the so-called ‘family glitch’ in the Affordable Care Act. The change would allow the total premium cost of all family members covered under an employer sponsored insurance plan to be considered when determining if the coverage is affordable rather than restricting the calculation to the cost for the employee only.
The Centers for Disease Control and Prevention (CDC) released a study today showing youth e-cigarette use remains high in 2022.
Twelve groups representing millions of patients across the nation will file an amicus curiae - or friend of the court - brief today urging the U.S. Supreme Court to protect access to quality health care for individuals with Medicaid health coverage.
More than 600 cancer patients, survivors and their loved ones from all 50 states and nearly every congressional district will be on Capitol Hill this week to make clear to members of Congress that cancer must be a national priority
President Biden is scheduled to deliver a speech in Boston this afternoon, sharing the latest developments in the Cancer Moonshot initiative to, “End cancer as we know it.”
Today U.S. District Court Judge Reed O’Connor issued a ruling that may lead Affordable Care Act-compliant health plans to deny coverage for or reinstate cost-sharing for certain preventive health services.
JUUL announced a tentative deal to pay nearly $440 million to settle a two-year, multi-state investigation into its underage marketing practices to attract young consumers to its addictive e-cigarettes. Evidence-based tobacco control is still critical.
Today the U.S. House of Representatives passed the Inflation Reduction Act, which includes several provisions that will reduce the costs of health care for millions of cancer patients and survivors.
Monica M. Bertagnolli, Doctorado en Medicina (MD), se desempeñará como la nueva Directora del Instituto Nacional del Cáncer (NCI), una función fundamental para garantizar la innovación continua en oncología.